Mergers: Big Pharma Shrinks Some

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-08-01-2001, Volume 0, Issue 0

London-GlaxoSmithKline is proposing to cut more than 2,000 jobs from its worldwide workforce of 100,000 as it seeks to generate the promised savings from its merger.